Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...

Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product ...

(AP) — The Trump administration’s vaccine advisers took up an old flu-shot debate: whether it’s time to wipe out the last small fraction of those vaccines that contain a controversial ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F. Kennedy Jr. replaced all its members.

With Flu Shot Vote, Kennedy’s Vaccine Skepticism Comes Full Circle The preservative thimerosal started Robert F. Kennedy Jr. down the path of questioning vaccine safety.

The Trump administration's vaccine advisers are bringing up an old flu-shot debate: Whether it's time to wipe out the last small fraction of those vaccines that contain a controversial ...

Pediatric flu deaths have surged in Michigan since the start of the COVID-19 pandemic, prompting experts to fear the numbers could become even worse down the road as vaccine hesitancy and distrust ...

The move to pull funding for drugmaker Moderna to continue testing an mRNA vaccine intended to protect people from the bird flu comes after Health Secretary Robert F. Kennedy Jr. announced the gove… ...

The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu.

Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals and sickening people.